Orthopeutics, L.P. was founded in May 2004 to develop and commercialize revolutionary nonsurgical solutions for common orthopedic problems. Our initial research focus was to explore a revolutionary new approach for the prevention of spinal disc degeneration and the associated low back pain. We discovered along the way that in addition to providing increased joint stability and tissue strength, our tissue matrix modification approach was capable of reducing disc bulge and tearing, increasing the flow of nutrients to these tissues, and of restoring the mechanics of other distressed tissues. Orthopeutics is now functioning as a technology licensing company, with current licensees actively commercializing our core technology as medical devices in the treatment of chronic low back pain, equine tendon and ligament repair, and other emerging application areas. We have conducted studies to support the licensing and commercialization of other micro-invasive, permanent, and cost-effective treatments in application areas such as:
- knee meniscus tears,
- spinal deformity,
- snoring and obstructive sleep apnea,
- equine breathing disorders,
- wound dehiscence,
- and a variety of other soft-tissue applications in humans and animals.
Orthopeutics holds 20+ issued US and international patents, and has numerous patents pending. Parties interested in discussing licensing opportunities are encouraged to contact us.